Brief: China Medical System Says Nmpa Approves Clinical Trials Of CMS-D017
15/07/2026 18:45
BRIEF-China Medical System Says Nmpa Approves Clinical Trials Of CMS-D017 July 15 (Reuters) - China Medical System Holdings Ltd 0867.HK:
NMPA APPROVES CLINICAL TRIALS OF CMS-D017 FOR AGE-RELATED MACULAR DEGENERATION
Further company coverage: 0867.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on China Medical System Holdings
See all newsBrief: China Medical System Says CMS-D001 Granted Drug Clinical Trial Approval Notice By NMPA
Brief: China Medical System Holdings Says Dermavon Receives NMPA Approval For Lumirix NDA For Atopic Dermatitis
China Medical System climbs most in six weeks on higher profit, dividend
China Medical System H1 revenue rises on jump in sales of innovative and exclusive products
AI shortens drug discovery to around 1 year in China, Insilico CEO says